Effect of Increased Radiotoxicity on Survival of Patients with Non-small Cell Lung Cancer Treated with Curatively Intended Radiotherapy

被引:0
|
作者
Holgersson, Georg [1 ,2 ]
Bergstrtom, Stefan [1 ,2 ]
Liv, Per [1 ]
Nilsson, Jonas [1 ,2 ]
Edlund, Per [2 ]
Blomberg, Carl [1 ,2 ]
Nyman, Jan [3 ]
Friesland, Signe [4 ]
Ekman, Simon [5 ]
Asklund, Thomas [6 ]
Henriksson, Roger [6 ]
Bergqvist, Michael [1 ,2 ,6 ]
机构
[1] Uppsala Univ, Gavle Hosp, Ctr Res & Dev, Gavle, Sweden
[2] Gavle Cent Hosp, Dept Oncol, SE-80187 Gavle, Sweden
[3] Sahlgrens Univ Hosp, Dept Oncol, Gothenburg, Sweden
[4] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden
[5] Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden
[6] Umea Univ Hosp, Dept Radiat Sci & Oncol, S-90185 Umea, Sweden
关键词
NSCLC; radiotherapy; toxicity; esophagitis; survival; RADIATION; CHEMOTHERAPY; CHEMORADIATION; CONCURRENT; THERAPY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To elucidate the impact of different forms of radiation toxicities (esophagitis, radiation pneumonitis, mucositis and hoarseness), on the survival of patients treated with curatively intended radiotherapy for non-small cell lung cancer (NSCLC). Patients and Methods: Data were individually collected retrospectively for all patients diagnosed with NSCLC subjected to curatively intended radiotherapy (>= 50 Gy) in Sweden during the time period 1990 to 2000. Results: Esophagitis was the only radiation-induced toxicity with an impact on survival (hazard ratio=0.83, p=0.016). However, in a multivariate model, with clinical-and treatment-related factors taken into consideration, the impact of esophagitis on survival was no longer statistically significant (hazard ratio=0.88, p=0.17). Conclusion: The effect on survival seen in univariate analysis may be related to higher radiation dose and to the higher prevalence of chemotherapy in this group. The results do not suggest that the toxicities examined have any detrimental effect on overall survival.
引用
收藏
页码:5491 / 5497
页数:7
相关论文
共 50 条
  • [31] Radiotherapy of non-small cell lung cancer
    Kleine, P.
    Flentje, M.
    PNEUMOLOGE, 2016, 13 (04): : 241 - +
  • [32] Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer
    Ouyang, Wen
    Yu, Jing
    Nuerjiang, Shuake
    Li, Zhijun
    Wang, Dajiang
    Wang, Xiaoyong
    Zhang, Junhong
    Xie, Conghua
    CANCER MEDICINE, 2019, 8 (10): : 4605 - 4614
  • [33] Racial Differences in Toxicity in Non-Small Cell Lung Cancer Patients Treated with Thoracic Radiotherapy
    Laucis, A. M.
    Hochstedler, K.
    Schipper, M.
    Paximadis, P. A.
    Boike, T. P.
    Bergsma, D. P.
    Spratt, D. E.
    Dess, R. T.
    Mietzel, M.
    Dominello, M. M.
    Matuszak, M. M.
    Jagsi, R.
    Hayman, J. A.
    Pierce, L. J.
    Jolly, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E148 - E148
  • [34] THE PROGNOSTIC IMPORTANCE OF PLATELET PARAMETERS IN NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH RADIOTHERAPY
    Maslyk, B.
    Deja, R.
    Suwinski, R.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S257 - S257
  • [35] Radiomic analysis of non-small cell lung cancer (NSCLC) patients treated with radical radiotherapy
    Hindocha, S.
    Orton, M.
    Doran, S.
    Philipps, L.
    Koh, D-M
    Blackledge, M.
    Lee, R.
    LUNG CANCER, 2020, 139 : S41 - S41
  • [36] Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy
    Barron, Feliciano
    Sanchez, Roberto
    Arroyo-Hernandez, Marisol
    Blanco, Carolina
    Zatarain-Barron, Zyanya L.
    Catalan, Rodrigo
    Ramos-Ramirez, Maritza
    Cardona, Andres F.
    Flores-Estrada, Diana
    Arrieta, Oscar
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [37] Predictors of Survival in Patients With Non-Small Cell Lung Cancer
    Luo, Juhua
    Chen, Yea-Jyh
    Narsavage, Georgia L.
    Ducatman, Alan
    ONCOLOGY NURSING FORUM, 2012, 39 (06) : 609 - 616
  • [38] Survival outcomes of palliative thoracic radiotherapy in non-small cell lung cancer
    Merrick, Christopher
    Tough, Fay
    LUNG CANCER, 2022, 165 : S59 - S59
  • [39] Association between intensity modulated radiotherapy and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapy
    Koshy, Matthew
    Malik, Renuka
    Spiotto, Michael
    Mahmood, Usama
    Rusthoven, Chad G.
    Sher, David J.
    LUNG CANCER, 2017, 108 : 222 - 227
  • [40] The relationship between dosimetric factors, side effects, and survival in patients with non-small cell lung cancer treated with definitive radiotherapy
    Okumus, Dilruba
    Sarihan, Sureyya
    Gozcu, Sema
    Sigirli, Deniz
    MEDICAL DOSIMETRY, 2017, 42 (03) : 169 - 176